Research Communication: Breath Testing for Colorectal Cancer Detection in Patients With a Positive Fecal Immunochemical Test: A Multicentre Prospective Cross‐Sectional Study With External Validation
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.70207 ↗At a glance
Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2025. Written by Milou L M van Riswijk and 6 co-authors. Institution: Department of Gastroenterology and Hepatology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Major MEDLINE topics: Colorectal Neoplasms, Early Detection of Cancer, Feces, Electronic Nose. Cited 9 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: European Regional Development Fund, Maag Lever Darm Stichting.
Abstract (original language)
Colorectal cancer (CRC) screening using fecal immunochemical tests (FIT) is suboptimal. This multicentre study evaluated an electronic nose (e‐nose) for CRC detection in FIT‐positive patients, along with reproducibility and external validation. Among 3469 participants (40.1% female, median age 64.3y), CRC was diagnosed in 5.0%; 25.1% had a normal colonoscopy. The e‐nose showed poor diagnostic performance (AUC 0.542; sensitivity 39.5%; specificity 68.3%) and low reproducibility (ICC 0.22). Despite high patient acceptability (95.3% willingness‐to‐repeat), these findings suggest e‐nose technology is not yet ready for clinical implementation. Further research is needed to standardise and validate e‐nose devices before supplementing current screening methods. Clinicaltrials.gov Identifier NCT03346005 and NCT04357158.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Gastroenterology and Hepatology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
- Dept. of Gastroenterology and Hepatology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
- Dept. of Gastroenterology and Hepatology, Bernhoven, Uden, the Netherlands.
- Dept. of Gastroenterology and Hepatology, Isala Hospital, Zwolle, the Netherlands.
- Dept. of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
ORCID profiles: Milou L M van Riswijk
Funding
- European Regional Development Fund
- Maag Lever Darm Stichting
Cite
APA
van Riswijk, M. L. M., van Keulen, K. E., Tan, A. C. I. T. L., Schrauwen, R. W. M., de Vos Tot Nederveen Cappel, W. H., Siersema, P. D., & eNose CRC study group (2025). Research Communication: Breath Testing for Colorectal Cancer Detection in Patients With a Positive Fecal Immunochemical Test: A Multicentre Prospective Cross‐Sectional Study With External Validation. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70207
Vancouver
van Riswijk MLM, van Keulen KE, Tan ACITL, Schrauwen RWM, de Vos Tot Nederveen Cappel WH, Siersema PD, et al. Research Communication: Breath Testing for Colorectal Cancer Detection in Patients With a Positive Fecal Immunochemical Test: A Multicentre Prospective Cross‐Sectional Study With External Validation. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70207
BibTeX
@article{vanRiswijk2025,
author = {van Riswijk, Milou L M and van Keulen, Kelly E and Tan, Adriaan C I T L and Schrauwen, Ruud W M and de Vos Tot Nederveen Cappel, Wouter H and Siersema, Peter D and eNose CRC study group, eNose CRC study group},
title = {Research Communication: Breath Testing for Colorectal Cancer Detection in Patients With a Positive Fecal Immunochemical Test: A Multicentre Prospective Cross‐Sectional Study With External Validation},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.70207}
}
EUVIMED